<DOC>
	<DOCNO>NCT01761500</DOCNO>
	<brief_summary>Non-Hodgkin 's lymphoma aggressive malignance disease child adolescents . This study design evaluate efficacy toxicity modify NHL-BFM-90 protocol Chinese child adolescents Non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Improve Survival Rate Chinese Children Adolescents With Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>Non-Hodgkin 's Lymphoma ( NHL ) child adolescent include Burkitt 's lymphoma ( BL ) , diffuse large B cell lymphoma ( DLBL ) , anaplastic large cell lymphoma ( ALCL ) lymphoblastic lymphoma ( LBL ) . These subtypes NHL aggressive group diseases . At present , developed country , 80 90 % child NHL cure intensive , risk-adapted chemotherapy.The best protocol include BFM-90 , LMB-89 FAB/LMB/96 . However , develop country , low moderate income , limited availability resource obstacle use complicate intensive protocols.As , simple protocol , CHOP protocol , often use treat child adolescent NHL , thus result poor survival rate . To improve survival rate Chinese child adolescent NHL , This study design evaluate efficacy toxicity modify NHL-BFM -90 protocol Chinese child adolescent NHL .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>1 . Untreated child adolescent NonHodgkin 's lymphoma 2 . Age ≤ 20 year 3 . The informed consent guardian obtain . 1 . Recurrence NonHodgkin 's lymphoma 2 . Age ＞20 year 3 . No abide protocol</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Non-Hodgkin 's lymphoma ;</keyword>
	<keyword>Childhood adolescence ;</keyword>
	<keyword>Survival Rate</keyword>
</DOC>